Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathway.
about
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinomaCCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signalingComing of Age in the Life ofMolecular biology and therapeutics in musculoskeletal oncology.Insulin promotes rat retinal neuronal cell survival in a p70S6K-dependent manner.Defining the gene expression signature of rhabdomyosarcoma by meta-analysis.PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis.Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma.ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damageIGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma.Zinc and cancer: implications for LIV-1 in breast cancer.Caspase activity and apoptotic signaling in proliferating C2C12 cells following cisplatin or A23187 exposure.HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924.Targeting the PI3-kinase/Akt/mTOR signaling pathway.Molecular biology of head and neck cancer: risks and pathways.Development of targeted therapy for squamous cell carcinomas of the head and neck.Protection of neuronal cell death against diabetes-induced apoptosis by Fas blocker ZB4.Proteolytic cleavage of p70 ribosomal S6 kinase by caspase-3 during DNA damage-induced apoptosis.The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells.Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells.
P2860
Q24607285-65B5074D-3630-448A-86C7-2C034E5B96D0Q24672058-22B066E1-5FF1-4D6A-8EB1-5ABAC275D3F3Q28389985-464714D9-E3FC-41E3-A588-F2AE675A561FQ30426953-8B2A6CC5-1F9D-4D06-AA76-29EF5427F8EAQ33195730-84B10B91-B2C8-4220-9888-92354EA268B0Q33262934-B62BA8A3-D28C-4C53-87BE-4C7A12EAC34BQ33862650-8CE5C017-CF88-4215-9436-9A51B65BF503Q34419308-B7741F28-0A61-49C9-ADAE-5C7F3DA2D20BQ34753639-7D37F1FC-D7F9-49D6-9603-5D653922918DQ35555492-E183069A-1481-411A-AC9D-D1DBDC4AF9B6Q36126413-4EFCA103-9607-4302-B4F1-BDEDDC2345B3Q36783672-3DFB69B0-D88A-455A-ADC8-BDE94D249571Q37038068-33373F9C-7859-4E63-AB81-9BB69DA16201Q37265126-C44EA4E7-3D39-4947-90B4-A256EF967A46Q37325829-696E1E64-380F-4755-9B91-8E3520923B37Q37854706-4519864D-766B-4E9B-B766-E0C9133A44E6Q38990528-B907688A-4986-4F66-B6C3-55B7A563A420Q39887685-B16C9009-FB72-4EAF-A052-25890A0D00D1Q41582917-6FFF889C-6724-459E-9073-C507FE3283CFQ44645813-B430DBB4-2F50-4529-985E-88AC7C7FB92F
P2860
Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathway.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effect of insulin-like growth ...... through p70 S6 kinase pathway.
@ast
Effect of insulin-like growth ...... through p70 S6 kinase pathway.
@en
type
label
Effect of insulin-like growth ...... through p70 S6 kinase pathway.
@ast
Effect of insulin-like growth ...... through p70 S6 kinase pathway.
@en
prefLabel
Effect of insulin-like growth ...... through p70 S6 kinase pathway.
@ast
Effect of insulin-like growth ...... through p70 S6 kinase pathway.
@en
P2860
P356
P1433
P1476
Effect of insulin-like growth ...... through p70 S6 kinase pathway.
@en
P2093
Lee J Helman
Xiaolin Wan
P2860
P304
P356
10.1038/SJ.NEO.7900242
P577
2002-09-01T00:00:00Z